Target Price | $26.50 |
Price | $25.04 |
Potential |
5.83%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Farmers & Merchants Bancorp, Inc. 2026 .
The average Farmers & Merchants Bancorp, Inc. target price is $26.50.
This is
5.83%
register free of charge
$28.00
11.82%
register free of charge
$25.00
0.16%
register free of charge
|
|
A rating was issued by 3 analysts: 0 Analysts recommend Farmers & Merchants Bancorp, Inc. to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Farmers & Merchants Bancorp, Inc. stock has an average upside potential 2026 of
5.83%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 178.38 | 115.21 |
15.01% | 35.41% | |
Net Margin | 14.61% | 25.09% |
1.08% | 71.69% |
2 Analysts have issued a sales forecast Farmers & Merchants Bancorp, Inc. 2025 . The average Farmers & Merchants Bancorp, Inc. sales estimate is
This results in the following potential growth metrics:
3 Farmers & Merchants Bancorp, Inc. Analysts have issued a net profit forecast 2025. The average Farmers & Merchants Bancorp, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.90 | 2.11 |
13.77% | 11.05% | |
P/E | 11.99 | |
EV/Sales | 4.18 |
3 Analysts have issued a Farmers & Merchants Bancorp, Inc. forecast for earnings per share. The average Farmers & Merchants Bancorp, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Farmers & Merchants Bancorp, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.